-
FDA approves Sandoz dermatology drug
PRINCETON, N.J. — The Food and Drug Administration has approved a drug made by Sandoz for treating symptoms of various skin diseases.
Sandoz, the generics arm of Swiss drug maker Novartis, announced the approval of desoximetasone ointment in the 0.25% strength. The drug is a generic version of Taro Pharmaceutical Industries' Topicort and, according to Sandoz, is the first Fougera dermatology product Sandoz has launched since its $1.5 billion acquisition of the company in May 2012.
-
Lansinoh launches breast pump, baby bottle and nonmedicinal pain reliever for breast-feeding moms
WASHINGTON — Lansinoh Laboratories on Friday announced the launch of the new Lansinoh Affinity Pro Double Electric Breast Pump, featuring three customizable pumping styles that can help moms maximize milk flow and comfort to enhance breastfeeding success. The new Lansinoh Affinity Pro pump was recognized as a finalist in the Juvenile Products Manufacturers Association 2012 Innovation Awards, the company reported.